BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

Abstract Immunogenicity related to treatment with TNF inhibitors (TNFi) is one of the causes for the decreased attainment of clinical response in patients with rheumatoid arthritis (RA). The B-cell activating factor (BAFF) may be playing a role in the development of immunogenicity. The objective of...

Full description

Bibliographic Details
Main Authors:	Borja Hernández-Breijo, Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, Ioannis Parodis, Johanna E. Gehin, Ana Martínez-Feito, Marta Novella-Navarro, Araceli Mezcua, David J. Warren, Pilar Nozal, Dora Pascual-Salcedo, Alejandro Balsa
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-06-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-91177-4

Similar Items

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis
by: Borja Hernández-Breijo, et al.
Published: (2021-06-01)

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
by: Borja Hernández-Breijo, et al.
Published: (2019-02-01)

Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis
by: Borja Hernández-Breijo, et al.
Published: (2021-06-01)

Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis
by: Eulalia Rodríguez-Martín, et al.
Published: (2020-08-01)

Risk Factors for Developing Rheumatoid Arthritis in Patients With Undifferentiated Arthritis and Inflammatory Arthralgia
by: Marta Novella-Navarro, et al.
Published: (2021-06-01)

Immunogenicity of TNF-Inhibitors
by: Sadaf Atiqi, et al.
Published: (2020-02-01)

Data for the crystal structure of APRIL–BAFF–BAFF heterotrimer
by: Klaus Maskos, et al.
Published: (2016-03-01)

BAFF and BAFF-Receptor in B Cell Selection and Survival
by: Cristian R. Smulski, et al.
Published: (2018-10-01)

BAFF controls neural cell survival through BAFF receptor.
by: Satoru Tada, et al.
Published: (2013-01-01)

Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab
by: Christine Kowalczyk-Quintas, et al.
Published: (2018-11-01)

BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway
by: Shanshan Hu, et al.
Published: (2019-06-01)

High immunogenic influenza virus-like particles containing APRIL or BAFF for multi-subtype vaccine development
by: Hong, Jo-Yu, et al.
Published: (2017)

B cell alterations during BAFF inhibition with belimumab in SLEResearch in context
by: Daniel Ramsköld, et al.
Published: (2019-02-01)

IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases
by: Piotr Wojdasiewicz, et al.
Published: (2019-06-01)

BAFF polymorphisms and serum levels of BAFF in Tunisian systemic lupus erythematosus patients
by: Laamiri Nacira, et al.
Published: (2012-11-01)

Development of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics
by: Jenny Hu, et al.
Published: (2014-02-01)

Expression of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteristics and survival outcomes.
by: Ya-Jun Li, et al.
Published: (2012-01-01)

Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells.
by: Melanie Rauch, et al.
Published: (2009-01-01)

The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway.
by: De-Hong Wu, et al.
Published: (2015-01-01)

Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?
by: Diego Benavent, et al.
Published: (2020-11-01)

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
by: Marta Novella-Navarro, et al.
Published: (2020-12-01)

Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax®23.
by: Alena Roth, et al.
Published: (2016-01-01)

Expression of TNF-superfamily members BAFF and APRIL in breast cancer: Immunohistochemical study in 52 invasive ductal breast carcinomas
by: Stathopoulos Efstathios N, et al.
Published: (2008-03-01)

Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen
by: Vivien Hébert, et al.
Published: (2021-05-01)

BAFF, B cells and tumour immunity
by: Tun, Paul Fei-Tun
Published: (2005)

The complexity of the BAFF forms and their functional implications
by: Lahiri, Ayan
Published: (2014)

BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid
by: Mahya Eslami, et al.
Published: (2020-11-01)

The role of the BAFF receptor in B cell survival
by: Fountain, Kathryn
Published: (2017)

Value of immunogenicity in the TNF-α inhibitor treatment of rheumatic diseases
by: N. V. Chichasova
Published: (2016-01-01)

Monitoring of anti-TNF biological treatments
by: Ramiro S, et al.
Published: (2010-11-01)

Association of BAFF gene polymorphisms with multiple sclerosis progression
by: I. V. Smagina, et al.
Published: (2020-02-01)

The effects of BAFF on T lymphocytes in chronic obstructive pulmonary disease
by: Shupei Gao, et al.
Published: (2020-03-01)

BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
by: Diana Prieto-Peña, et al.
Published: (2021-06-01)

BAFF receptor antibody for mantle cell lymphoma therapy
by: Keman Zhang, et al.
Published: (2021-01-01)

Characterization of BAFF and APRIL subfamily receptors in rainbow trout (Oncorhynchus mykiss). Potential role of the BAFF / APRIL axis in the pathogenesis of proliferative kidney disease.
by: Aitor G Granja, et al.
Published: (2017-01-01)

CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. A. Panafidina, et al.
Published: (2016-07-01)

Testosterone is an endogenous regulator of BAFF and splenic B cell number
by: Anna S. Wilhelmson, et al.
Published: (2018-05-01)

APRIL and BAFF: novel biomarkers for central nervous system lymphoma
by: Matthias Mulazzani, et al.
Published: (2019-10-01)

Expression of BAFF and BR3 in patients with systemic lupus erythematosus
by: J.H. Duan, et al.
Published: (2016-03-01)

Therapeutic Effects of PADRE-BAFF Autovaccine on Rat Adjuvant Arthritis
by: Guo-dong Feng, et al.
Published: (2014-01-01)